ProfileGDS4718 / 210788_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 91% 94% 89% 94% 95% 86% 87% 94% 94% 94% 93% 93% 94% 89% 85% 94% 95% 93% 91% 81% 95% 94% 96% 95% 91% 91% 96% 84% 94% 90% 89% 91% 96% 94% 94% 92% 88% 94% 93% 89% 97% 88% 95% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5194791
GSM549102patient 115, normal, homogenized [OPG study]9.981794
GSM549104patient 119, normal, homogenized [OPG study]9.0673689
GSM549108patient 138, normal, homogenized [OPG study]9.9492594
GSM549119patient 077, normal, homogenized [OPG study]10.284195
GSM549133patient 032, cancer, homogenized [OPG study]8.7662786
GSM549139patient 042, cancer, homogenized [OPG study]8.7703287
GSM549099patient 107, normal, homogenized [OPG study]9.9757194
GSM549109patient 139, normal, homogenized [OPG study]10.149194
GSM549110patient 046, normal, homogenized [OPG study]10.074694
GSM549114patient 063, normal, homogenized [OPG study]10.01693
GSM549122patient 082, normal, homogenized [OPG study]9.776893
GSM549134patient 033, cancer, homogenized [OPG study]9.9416194
GSM549136patient 036, cancer, homogenized [OPG study]9.1014189
GSM549140patient 044, cancer, homogenized [OPG study]8.5097285
GSM549111patient 047, normal, homogenized [OPG study]10.217594
GSM549113patient 057, normal, homogenized [OPG study]10.524295
GSM549132patient 031, cancer, homogenized [OPG study]9.7922393
GSM549137patient 038, cancer, homogenized [OPG study]9.3207491
GSM549142patient 047, cancer, homogenized [OPG study]7.7474181
GSM549100patient 110, normal, homogenized [OPG study]10.272695
GSM549107patient 135, normal, homogenized [OPG study]10.1394
GSM549115patient 068, normal, homogenized [OPG study]10.647496
GSM549116patient 072, normal, homogenized [OPG study]10.2595
GSM549120patient 078, normal, homogenized [OPG study]9.392591
GSM549131patient 030, cancer, homogenized [OPG study]9.4137691
GSM549118patient 074, normal, homogenized [OPG study]10.58996
GSM549129patient 027, cancer, homogenized [OPG study]8.2859884
GSM549123patient 088, normal, homogenized [OPG study]10.154694
GSM549124patient 006, cancer, homogenized [OPG study]8.9843290
GSM549126patient 015, cancer, homogenized [OPG study]8.9852389
GSM549128patient 025, cancer, homogenized [OPG study]9.377891
GSM549103patient 117, normal, homogenized [OPG study]10.395896
GSM549117patient 073, normal, homogenized [OPG study]10.103994
GSM549138patient 041, cancer, homogenized [OPG study]10.00594
GSM549141patient 045, cancer, homogenized [OPG study]9.6725492
GSM549130patient 028, cancer, homogenized [OPG study]8.8451688
GSM549101patient 111, normal, homogenized [OPG study]10.011494
GSM549105patient 128, normal, homogenized [OPG study]9.6827693
GSM549106patient 134, normal, homogenized [OPG study]9.1404389
GSM549112patient 048, normal, homogenized [OPG study]10.885697
GSM549125patient 011, cancer, homogenized [OPG study]8.8177488
GSM549127patient 024, cancer, homogenized [OPG study]10.091895
GSM549135patient 035, cancer, homogenized [OPG study]10.432296